These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24461562)

  • 1. Synthesis of a C-phosphonate mimic of maltose-1-phosphate and inhibition studies on Mycobacterium tuberculosis GlgE.
    Veleti SK; Lindenberger JJ; Ronning DR; Sucheck SJ
    Bioorg Med Chem; 2014 Feb; 22(4):1404-11. PubMed ID: 24461562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a poly-hydroxypyrolidine-based inhibitor of Mycobacterium tuberculosis GlgE.
    Veleti SK; Lindenberger JJ; Thanna S; Ronning DR; Sucheck SJ
    J Org Chem; 2014 Oct; 79(20):9444-50. PubMed ID: 25137149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of Mycobacterium tuberculosis GlgE and complexes with non-covalent inhibitors.
    Lindenberger JJ; Veleti SK; Wilson BN; Sucheck SJ; Ronning DR
    Sci Rep; 2015 Aug; 5():12830. PubMed ID: 26245983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 2-deoxy-2,2-difluoro-α-maltosyl fluoride and its X-ray structure in complex with Streptomyces coelicolor GlgEI-V279S.
    Thanna S; Lindenberger JJ; Gaitonde VV; Ronning DR; Sucheck SJ
    Org Biomol Chem; 2015 Jul; 13(27):7542-50. PubMed ID: 26072729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of GlgE as a new target for tuberculosis.
    Kalscheuer R; Jacobs WR
    Drug News Perspect; 2010 Dec; 23(10):619-24. PubMed ID: 21180647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Glucan biosynthesis and the GlgE pathway in Mycobacterium tuberculosis.
    Bornemann S
    Biochem Soc Trans; 2016 Feb; 44(1):68-73. PubMed ID: 26862190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A temperature-sensitive Mycobacterium smegmatis glgE mutation leads to a loss of GlgE enzyme activity and thermostability and the accumulation of α-maltose-1-phosphate.
    Syson K; Batey SFD; Schindler S; Kalscheuer R; Bornemann S
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129783. PubMed ID: 33166604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of Mycobacterium thermoresistibile GlgE defines novel conformational states that contribute to the catalytic mechanism.
    Mendes V; Blaszczyk M; Maranha A; Empadinhas N; Blundell TL
    Sci Rep; 2015 Nov; 5():17144. PubMed ID: 26616850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an alpha-glucan pathway.
    Kalscheuer R; Syson K; Veeraraghavan U; Weinrick B; Biermann KE; Liu Z; Sacchettini JC; Besra G; Bornemann S; Jacobs WR
    Nat Chem Biol; 2010 May; 6(5):376-84. PubMed ID: 20305657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of Streptomyces maltosyltransferase GlgE, a homologue of a genetically validated anti-tuberculosis target.
    Syson K; Stevenson CEM; Rejzek M; Fairhurst SA; Nair A; Bruton CJ; Field RA; Chater KF; Lawson DM; Bornemann S
    J Biol Chem; 2011 Nov; 286(44):38298-38310. PubMed ID: 21914799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based
    Singh K; Sharma A; Upadhyay TK; Hayat-Ul-Islam M; Khan MKA; Dwivedi UN; Sharma R
    Curr Comput Aided Drug Des; 2022; 18(3):213-227. PubMed ID: 35747982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insight into how Streptomyces coelicolor maltosyl transferase GlgE binds α-maltose 1-phosphate and forms a maltosyl-enzyme intermediate.
    Syson K; Stevenson CE; Rashid AM; Saalbach G; Tang M; Tuukkanen A; Svergun DI; Withers SG; Lawson DM; Bornemann S
    Biochemistry; 2014 Apr; 53(15):2494-504. PubMed ID: 24689960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis maltosyltransferase GlgE, a genetically validated antituberculosis target, is negatively regulated by Ser/Thr phosphorylation.
    Leiba J; Syson K; Baronian G; Zanella-Cléon I; Kalscheuer R; Kremer L; Bornemann S; Molle V
    J Biol Chem; 2013 Jun; 288(23):16546-16556. PubMed ID: 23609448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Glucan pathway as a novel Mtb drug target: structural insights and cues for polypharmcological targeting of GlgB and GlgE.
    Agrawal P; Gupta P; Swaminathan K; Parkesh R
    Curr Med Chem; 2014; 21(35):4074-84. PubMed ID: 25174919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Network for the Biosynthesis of Intra- and Extracellular α-Glucans Required for Virulence of Mycobacterium tuberculosis.
    Koliwer-Brandl H; Syson K; van de Weerd R; Chandra G; Appelmelk B; Alber M; Ioerger TR; Jacobs WR; Geurtsen J; Bornemann S; Kalscheuer R
    PLoS Pathog; 2016 Aug; 12(8):e1005768. PubMed ID: 27513637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental delay in a Streptomyces venezuelae glgE null mutant is associated with the accumulation of α-maltose 1-phosphate.
    Miah F; Bibb MJ; Barclay JE; Findlay KC; Bornemann S
    Microbiology (Reading); 2016 Jul; 162(7):1208-1219. PubMed ID: 27121970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-bound Structures and Site-directed Mutagenesis Identify the Acceptor and Secondary Binding Sites of Streptomyces coelicolor Maltosyltransferase GlgE.
    Syson K; Stevenson CE; Miah F; Barclay JE; Tang M; Gorelik A; Rashid AM; Lawson DM; Bornemann S
    J Biol Chem; 2016 Oct; 291(41):21531-21540. PubMed ID: 27531751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of α-Glucan by GlgE and GlgB in Mycobacteria and Streptomycetes.
    Rashid AM; Batey SF; Syson K; Koliwer-Brandl H; Miah F; Barclay JE; Findlay KC; Nartowski KP; Khimyak YZ; Kalscheuer R; Bornemann S
    Biochemistry; 2016 Jun; 55(23):3270-84. PubMed ID: 27221142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sengupta S; Roy D; Bandyopadhyay S
    J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.
    Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY
    Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.